265 related articles for article (PubMed ID: 31695695)
41. Treatment and clinical outcomes in anti-p200 pemphigoid: a systematic review.
Laufer Britva R; Amber KT; Cohen AD; Kridin K
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):465-472. PubMed ID: 31536652
[TBL] [Abstract][Full Text] [Related]
42. Anti-P 200 pemphigoid - The most common floor binding subepidermal autoimmune bullous disease in a tertiary care center in south India.
Rai R; Anand JB; Shanmugasekar C; Arunprasath P; Chaitra V; Zillikens D; Schimdt E
Indian J Dermatol Venereol Leprol; 2021; 87(6):787-791. PubMed ID: 34160166
[TBL] [Abstract][Full Text] [Related]
43. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
[No Abstract] [Full Text] [Related]
44. Nonbullous pemphigoid: A systematic review.
Lamberts A; Meijer JM; Jonkman MF
J Am Acad Dermatol; 2018 May; 78(5):989-995.e2. PubMed ID: 29102490
[TBL] [Abstract][Full Text] [Related]
45. Anti-laminin γ1 pemphigoid accompanied by autoantibodies to laminin α3 and γ2 subunits of laminin-332.
Kamata M; Fujita H; Hamanaka T; Takahashi K; Koga H; Hashimoto T; Sato S
JAMA Dermatol; 2013 Dec; 149(12):1437-9. PubMed ID: 24154702
[No Abstract] [Full Text] [Related]
46. Human skin basement membrane in health and in autoimmune diseases.
Chan LS
Front Biosci; 1997 Jul; 2():d343-52. PubMed ID: 9232815
[TBL] [Abstract][Full Text] [Related]
47. Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited.
van Beek N; Dohse A; Riechert F; Krull V; Recke A; Zillikens D; Schmidt E
Br J Dermatol; 2014 Apr; 170(4):943-7. PubMed ID: 24734947
[TBL] [Abstract][Full Text] [Related]
48. Autoimmune blistering dermatoses as systemic diseases.
Vassileva S; Drenovska K; Manuelyan K
Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
[TBL] [Abstract][Full Text] [Related]
49. The autoantigen in anti-p200 pemphigoid is synthesized by keratinocytes and fibroblasts and is distinct from nidogen-2.
Hofmann SC; Voith U; Sasaki T; Trüeb RM; Nischt R; Bruckner-Tuderman L
J Invest Dermatol; 2008 Jan; 128(1):87-95. PubMed ID: 17637825
[TBL] [Abstract][Full Text] [Related]
50. Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features.
Mitsuya J; Hara H; Ito K; Ishii N; Hashimoto T; Terui T
Br J Dermatol; 2008 Jun; 158(6):1354-7. PubMed ID: 18294311
[TBL] [Abstract][Full Text] [Related]
51. Anti-p200 pemphigoid (anti-laminin-γ1 pemphigoid) demonstrating pathergy.
McCarty M; Zillikens D; Fivenson D
Int J Womens Dermatol; 2015 Dec; 1(4):173-174. PubMed ID: 28491985
[TBL] [Abstract][Full Text] [Related]
52. Anti-laminin γ1 pemphigoid associated with pustular psoriasis.
Igarashi M; Tsunemi Y; Koga H; Hashimoto T; Tateishi C; Tsuruta D; Ishii M; Kawashima M
Eur J Dermatol; 2014; 24(5):629-30. PubMed ID: 25075951
[No Abstract] [Full Text] [Related]
53. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
[TBL] [Abstract][Full Text] [Related]
54. Ex vivo pathogenicity of anti-laminin γ1 autoantibodies.
Florea F; Bernards C; Caproni M; Kleindienst J; Hashimoto T; Koch M; Sitaru C
Am J Pathol; 2014 Feb; 184(2):494-506. PubMed ID: 24300951
[TBL] [Abstract][Full Text] [Related]
55. Anti-laminin-gamma 1 Pemphigoid with Generalized Pustular Psoriasis and Psoriasis Vulgaris.
Fujimura Y; Natsuga K; Hamade Y; Nomura Y; Kaku Y; Muramatsu R; Shimizu H
Acta Derm Venereol; 2016 Jan; 96(1):120-1. PubMed ID: 26074471
[No Abstract] [Full Text] [Related]
56. Case of pemphigoid with immunoglobulin G antibodies to BP180 C-terminal domain and laminin-γ1 (p200) developed after pneumococcal vaccination.
Maki N; Hashimoto T; Yamada T; Ishii N; Tsuruta D; Demitsu T
J Dermatol; 2021 Jan; 48(1):101-105. PubMed ID: 32974956
[TBL] [Abstract][Full Text] [Related]
57. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
[TBL] [Abstract][Full Text] [Related]
58. Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5.
Kirtschig G; Marinkovich MP; Burgeson RE; Yancey KB
J Invest Dermatol; 1995 Oct; 105(4):543-8. PubMed ID: 7561156
[TBL] [Abstract][Full Text] [Related]
59. A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation.
Goto-Ohguchi Y; Nishie W; Akiyama M; Tateishi Y; Aoyagi S; Tsuji-Abe Y; Sawamura D; Ishii N; Hashimoto T; Shimizu H
Dermatology; 2009; 218(3):265-71. PubMed ID: 19060472
[TBL] [Abstract][Full Text] [Related]
60. Chronic bullous disease of childhood with IgG reactivity to p200 antigen.
Patsatsi A; Meltzanidou P; Katafigiotis S; Sotiriadis D; Schmidt E; Lambropoulos A
Int J Dermatol; 2017 Jul; 56(7):773-775. PubMed ID: 28436028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
